Structure-activity relationship of aza-steroids as PI-PLC inhibitors

Area of Science:

• Medicinal Chemistry
• Biochemistry
• Pharmacology

Background:

• Phosphatidylinositol phospholipase C (PI-PLC) plays a crucial role in cellular signaling pathways.
• Aza-steroids are a class of compounds with potential therapeutic applications.
• Inhibiting PI-PLC is a target for various diseases, including cancer.

Purpose of the Study:

• To synthesize novel aza-steroid derivatives.
• To evaluate their inhibitory activity against PI-PLC.
• To assess their potential for selective tumor cell growth inhibition.

Main Methods:

• Synthesis of various aza-steroid analogs, including diaza-cholesterol, diaza-estrone, and diaza-pregnane derivatives.
• In vitro enzymatic assays to determine PI-PLC inhibitory activity (IC50 values).
• In vitro tumor cell line screening (NCI) to assess growth inhibition (GI50 values).

Main Results:

• Several aza-steroid derivatives were identified as potent PI-PLC inhibitors, with IC50 values in the microM range.
• The stereochemistry at C-20 significantly influenced potency, with the 20alpha epimer being 50 times more active than the 20beta epimer.
• Epimers with a 3-hydroxyl group showed more potent PI-PLC inhibition compared to those with a 3-methoxyl group in diaza-pregnane derivatives.
• Epimeric mixture 8a exhibited selective growth inhibition against 54 tumor cell lines with a mean GI50 of 5.75 microM.

Conclusions:

• Aza-steroid derivatives, particularly those with specific structural features like the 20alpha epimer and 3-hydroxyl groups, are effective PI-PLC inhibitors.
• The synthesized compounds show promise as potential therapeutic agents, demonstrating both PI-PLC inhibition and selective anti-tumor activity.
• Further investigation into the structure-activity relationships of these aza-steroids could lead to the development of novel anti-cancer drugs.